|
A $1.75 million study, largest of its kind, is underway in the
United Kingdom aimed at improving the survival rates of patients
who have had surgery for colorectal cancer.
Doctors,
health economists and primary care specialists from the Universities
of Southampton and Oxford are leading the study that will involve
5,000 patients at 30 major hospital centers across the U.K.
Researchers
want to study the cost-effectiveness and clinical benefits of
various methods of managing patients following hospital treatment.
Post-operative treatments to be studied range from minimal intervention
all the way to maximum intervention where patients have regular
intensive scans, bowel endoscopies and chemical marker tests to
detect the presence of cancer cells.
Survival rates,
quality of life measurements and cost of medical care for each
treatment regimen will be compared during the five years post-surgery.
"We still
don't know the best way to manage people after their initial operation
even though this is a huge public health question," said Professor
John Primrose, professor of surgery at the University of Southampton.
"Practice varies around the country from people who get intensively
followed up with regular scans to other patients who are effectively
discharged and only return to their (doctors) if they have any
worrying symptoms."
The goal of
the study is to assess the clinical and cost-effectiveness of
intensive versus no scheduled follow-up, said Primrose. "It may
be that just having blood tests . . . might be as beneficial and
considerably cheaper than regular CT scans at the hospital. Or
it may be that intensive follow-ups increase survival rates enough
to make this the best option."
Patients participating
in the study will be referred to a multi-disciplinary team for
appropriate and rapid treatment as soon as any recurrent disease
is detected.
Other
sources: University of Southampton
|